Update on new treatments for rare ovarian tumours

In spite of their rarity when considered individually, the sum of all rare ovarian tumours (ROT) represent almost half of all ovarian malignancies. As such, their appropriate inclusion within dedicated clinical trials is essential for enhanced management. RECENT FINDINGS: Supported by institutional...

Descripción completa

Detalles Bibliográficos
Autores principales: Quesada, Stanislas, Bini, Marta, Lebreton, Coriolan, Ray-Coquard, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
GYNECOLOGIC CANCER: Edited by Gottfried E. Konecny
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788923/
https://www.ncbi.nlm.nih.gov/pubmed/36440753
http://dx.doi.org/10.1097/GCO.0000000000000836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788923/
https://www.ncbi.nlm.nih.gov/pubmed/36440753
http://dx.doi.org/10.1097/GCO.0000000000000836

Ejemplares similares